One of the most difficult challenges of the season was presented in Episode 7 of On Brand with Jimmy Fallon, where the ...
Significant progress has been achieved on the World Bank-funded 500kV Tarbela 5th Extension Transmission Line Project, which has ...
ISLAMABAD: Discrepancies between the technical assistance completion report (TCR) and the consultant reports, along with gaps ...
In phase 3 DREAM3R, first-line Imfinzi plus chemotherapy showed survival and response benefits in advanced mesothelioma, but results were inconclusive.
The decision was taken by the Cabinet Committee on State-Owned Enterprises (CCoSOEs), chaired by Finance Minister Muhammad ...
The first iteration of HER2-targeted drugs showed limited activity in bladder cancer, but the rise of antibody-drug ...
Early CRP levels may predict progression-free and overall survival among patients with stage IV MM undergoing first-line ICI therapy.
The phase 3 DREAM3R study randomized patients 2:1 to receive durvalumab 1500 mg every 3 weeks plus chemotherapy every 3 weeks for 4 to 6 cycles, followed by durvalumab maintenance 1500 mg every 4 ...
L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months with an objective response rate (ORR) of 25% – – Combination ...
L2 line arrays and KS21i subwoofers deployed to deliver reinforcement while minimising stage bleed at the century-old ...
Susan Galbraith, Ph.D., AZ’s oncology R&D chief, attributed Datroway’s strong efficacy to its ADC construct, specifically its ...
After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in ...